1Shahbazi M, Pravica V, Nasreen N, et al. Association between functional polymorphism in EGF gene and malignant melanoma.Lancet,2002. 359: 397-401.
2Messa C, Russo F, Caruso MG, et al. EGF, TGF-a and EGF-R in human colorectal adenocarcinoma. Acta Oncol, 1998,37: 285-289.
3McCarron SL, Bateman AC, Theaker JM, et al. EGF + 61 gene polymorphism and susceptibility to and prognostic markers in cutaneous malignant melanoma. Int J Cancer, 2003,107:673-675.
6Shahbazi M, Pravica V, Nasreen N, et al. Association between functional polymorphism in EGF gene and malignant melanoma. Lancet, 2002,359:397-401.
7Schulte CM, Goebell H, Roher HD, et al. C-509T polymorphism in the TGF-β1 gene promoter: impact on Crohn' s disease susceptibility and clinical course? Immunogenetics,2001,53 : 178-182.
8Krippl P, Langsenlehner U, Renner W, et al. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer, 2003,106:468 -471.
9Grainger DJ, Heathcote K, Chiano M, et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet, 1999,8:93-97.
10Buckmire MA, Parquet G, Greenway S, et al. Temporal expression of TGF-betal, EGF,and PDGF-BB in a model of colonic wound healing. J Surg Res, 1998,80:52-57.
